The diagnostics industry got off to a so-so start with PAMA reimbursement cuts, a weak flu season relative to 2018 and currency translation slowing the pace of year-over-year revenue … [Read more...]
EARNINGS REPORTS
DX Earnings Report: Lab Companies Finish 2018 Strong but Growth Slows for Established Firms
March 4, 2019
The diagnostics industry capped a robust 2018 with most companies posting strong fourth quarter results. Of course, every silver lining has a cloud. While widespread, gains were smaller than in 2017, … [Read more...]
INDUSTRY BUZZ
Earnings Report: Top Payers Announce Q3 Earnings
January 7, 2019
The country's five largest commercial payers posted strong results for the third quarter of fiscal year 2018: COMPANY QUARTERLY REVENUES PERFORMANCE Total Q3* 2018 YOY Wall … [Read more...]
REVENUES
DX Earnings Report: Q2 Lab Earnings Stay Strong but Not Quite at Q1 Levels
September 4, 2018
Q2 is shaping up to be another strong quarter—albeit not as stellar as Q1. Salient trends: Big labs continue posting impressive organic growth even as they enjoy the surge of new revenues from … [Read more...]
PAMA
PAMA Unlocks Golden Age for Innovative Diagnostics
July 30, 2018
By Chance Scott bio The publication of the 2018 Clinical Laboratory Fee Schedule (CLFS) in January saw a long and heated debate within the lab community come to fruition. When Congress … [Read more...]
REVENUES
DX Earnings Report: PAMA Cuts Make Little Dent on Q1 Lab Earnings
July 23, 2018
One quarter into its existence, the new PAMA Medicare Part B fee schedule seems to be having only a marginal impact on at least publicly traded labs. In fact, the recently published Q1 earnings … [Read more...]
REVENUES
DX Earnings Report: PAMA Cuts Make Little Dent on Q1 Lab Earnings
June 4, 2018
One quarter into its existence, the new PAMA Medicare Part B fee schedule seems to be having only a marginal impact on at least publicly traded labs. In fact, the recently published Q1 earnings … [Read more...]
REVENUES
Dx Earnings Report: Strong Q4 as Lab Companies End Year with a Bang
March 5, 2018
Big PAMA cuts may lay ahead in 2017, but the diagnostics industry had a robust 2017. While the entire year was strong, success was the most widespread in the fourth quarter with all but a few … [Read more...]
REVENUES
Dx Earnings Report: Strong Q3 Adds to Robust 2017 as PAMA Looms for 2018
December 5, 2017
Big labs continue to post impressive earnings. But the positive Q3 numbers may prove to be the calm before the PAMA storm—at least for major reference labs that generate significant revenues from … [Read more...]
INDUSTRY BUZZ
Company of the Month: Interpace Diagnostics
September 29, 2017
Question: What do Parsippany, NJ-based Interpace Diagnostics and butter have in common? Answer: They're both on a roll. July 27: The molecular lab announces that Cigna will cover its ThyGenX … [Read more...]
